These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 21969238

  • 1. Tau protein: a possible prognostic factor in optic neuritis and multiple sclerosis.
    Frederiksen J, Kristensen K, Bahl JM, Christiansen M.
    Mult Scler; 2012 May; 18(5):592-9. PubMed ID: 21969238
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosis.
    Beyer NH, Milthers J, Bonde Lauridsen AM, Houen G, Lautrup Frederiksen J.
    Scand J Clin Lab Invest; 2007 May; 67(7):696-706. PubMed ID: 17852796
    [Abstract] [Full Text] [Related]

  • 7. Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.
    Valis M, Talab R, Stourac P, Andrys C, Masopust J.
    Neuro Endocrinol Lett; 2008 Dec; 29(6):971-6. PubMed ID: 19112391
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.
    Szalardy L, Zadori D, Simu M, Bencsik K, Vecsei L, Klivenyi P.
    J Neurol Sci; 2013 Aug 15; 331(1-2):38-42. PubMed ID: 23706476
    [Abstract] [Full Text] [Related]

  • 11. The 14-3-3 protein in multiple sclerosis: a marker of disease severity.
    Colucci M, Roccatagliata L, Capello E, Narciso E, Latronico N, Tabaton M, Mancardi GL.
    Mult Scler; 2004 Oct 15; 10(5):477-81. PubMed ID: 15471360
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neither retinal nor brain atrophy can be shown in patients with isolated unilateral optic neuritis at the time of presentation.
    Kallenbach K, Sander B, Tsakiri A, Wanscher B, Fuglø D, Larsen M, Larsson H, Frederiksen JL.
    Mult Scler; 2011 Jan 15; 17(1):89-95. PubMed ID: 20847000
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA, Lin J, Sadiq SA.
    Arch Neurol; 2008 Feb 15; 65(2):232-5. PubMed ID: 18268193
    [Abstract] [Full Text] [Related]

  • 19. Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis.
    Jacobs LD, Kaba SE, Miller CM, Priore RL, Brownscheidle CM.
    Ann Neurol; 1997 Mar 15; 41(3):392-8. PubMed ID: 9066361
    [Abstract] [Full Text] [Related]

  • 20. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
    van der Vlies AE, Verwey NA, Bouwman FH, Blankenstein MA, Klein M, Scheltens P, van der Flier WM.
    Neurology; 2009 Mar 24; 72(12):1056-61. PubMed ID: 19307538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.